您要查找的是不是:
- Application of alpha, beta adrenergic receptor blockers during hemodialysis 受体阻滞剂在血液透析中的应用
- Adrenergic receptor blockers β受体阻滞剂
- Adrenergic beta receptor blockers 肾上腺素能β受体阻滞剂
- Is It the End of Beta Receptor Blockers as First-line Drugs for Hypertension? 受体阻滞剂作为高血压一线治疗药物的时代结束了吗?
- There is a strong evidence about the effect of angiotensin receptor blockers. 通过这些临床试验得到了强有力的证据证明血管紧张素受体阻滞剂的疗效。
- β - adrenergic receptor blocker β受体阻滞剂
- Adrenergic Receptor Blocker and Its Perioperative Application 肾上腺能受体阻滞药与围手术期应用
- Electively targeting of signaling pathways using protein kinase inhibitors would have a potential advantage over receptor blockers. 这种用来选择性地阻断信号转导途径的蛋白激酶抑制剂可能是一种潜在的有利的受体阻断剂。
- The patients of DN with hypertension were used angiotensin converting enzyme inhibitors(ACEI) or angiotensin receptor blockers(ARB) treatment and pioglitazone 15mg/d,12 weeks. 在常规降糖、有高血压者应用血管紧张素转换酶抑制剂(ACEI)或血管紧张素受体阻滞剂(ARB)降压的基础上,治疗组加用吡格列酮15mg/d口服,连用12周。
- Schupp M,Janke J,Clasen R,et al.Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity.Circulation,2004,109(17):2054. 王立军;马虹;廖新学;等.;替米沙坦上调人血管内皮细胞血管紧张素转换酶2的表达
- It also includes patients taking drugs that affect renal perfusion or function such as diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs) and possibly NSAIDS. 也包括正在服用影响肾灌注或肾功能药物的患者,此类药物如利尿剂、ACE抑制剂、血管紧张素受体抑制剂(ARBs)、或许NSAIDS。
- Cardiac Adrenergic Receptor and Its Autoantibody 心脏肾上腺素受体及其自身抗体研究进展
- Post hoc analyses of trials have observed reductions in atrial fibrillation among patients treated with angiotensin-converting enzyme inhibitors(ACEI) or angiotensin receptor blockers(ARBs). 近年来,大量研究显示通过抑制肾素-血管紧张素-醛固酮系统可对房颤有一定的预防作用。
- Adrenergic Receptor and Cardiovascular Diseases 肾上腺素能受体与心血管疾病
- A sympathomimetic that acts mainly by causing release of norepinephrine but also has direct agonist activity at some adrenergic receptors. 一种拟交感神经药物,主要以引发去甲肾上腺素释放起作用,对交感神经受体也有直接的促进作用。
- Angiotensin receptor blockers, the class of drugs to which candesartan belongs, are thought to reduce the actions of the hormone angiotensin II and therefore impact on the renin-angiotensin system. 坎地沙坦,属于一种血管紧张素受体阻断剂,可以降低血管紧张素受体II的作用并影响肾素血管紧张素系统。
- adrenergic receptor mimetic agent 肾上腺素能受体模拟剂
- Anti betal - adrenergic receptor autoantibodies 抗β1-AR自身抗体
- Application of beta receptor blockers in ACS 受体阻滞剂在急性冠脉综合征中的应用
- Human adrenergic receptor polymorphism and hypertension 人类肾上腺素能受体基因多态性与高血压